News
10-23-2012, 09:00 AM
The innovator's award recognises Josef Penninger's work in identifying a key molecular pathway how hormone replacement therapies and contraceptive pills can lead to breast cancer. His team provided the first genetic proof that a protein called RANKL is the master regulator of bone loss, which has contributed to the development of a novel drug already approved for the treatment of osteoporosis and skeletal related events in multiple cancers.
More... (http://www.news-medical.net/news/20121023/Austrian-researchers-receive-2474-million-award-to-verify-new-breast-cancer-pathways.aspx)
More... (http://www.news-medical.net/news/20121023/Austrian-researchers-receive-2474-million-award-to-verify-new-breast-cancer-pathways.aspx)